human
rhinovirus
hrv
repres
singl
import
etiolog
agent
common
cold
frequent
caus
acut
respiratori
infect
human
current
perform
avail
anim
model
immun
studi
use
hrv
challeng
limit
cotton
rat
sigmodon
hispidu
wellrecogn
model
studi
human
respiratori
viral
infect
work
show
without
requir
genet
modif
either
host
viru
intranas
infect
cotton
rat
result
measur
isol
infect
viru
lower
respiratori
tract
patholog
mucu
product
express
interferonactiv
gene
intramuscular
immun
live
gener
robust
protect
immun
correl
high
serum
level
neutral
antibodi
addit
cotton
rat
treat
prophylact
hyperimmun
serum
protect
intranas
challeng
final
protect
immun
effici
transfer
mother
newborn
anim
result
substanti
reduct
infecti
viru
load
lung
follow
intranas
challeng
overal
result
demonstr
cotton
rat
provid
valuabl
addit
model
develop
option
test
vaccin
prophylact
therapi
rhinoviru
infect
human
rhinovirus
hrv
repres
import
etiolog
agent
common
cold
frequent
caus
acut
respiratori
infect
human
hrv
singlestrand
positivesens
rna
virus
member
picornavirida
famili
genu
enteroviru
includ
three
far
recogn
speci
rhinoviru
b
c
also
speci
enteroviru
aj
recent
sequenc
analysi
known
hrv
serotyp
classifi
within
speci
b
genom
rna
correspond
speci
rhinoviru
c
allow
better
understand
evolutionari
relat
among
virus
classifi
within
speci
also
structur
implic
genet
variabl
gene
encod
capsid
protein
hrv
current
frequent
detect
viru
associ
hospit
acut
respiratori
ill
young
children
elderli
also
frequent
opportunist
pathogen
transplant
recipi
addit
hrv
infect
link
exacerb
episod
asthmat
chronic
obstruct
pulmonari
diseas
copd
patient
due
occurr
hrv
serotyp
extens
sequenc
variabl
antigen
site
lack
anim
model
test
efficaci
approach
prevent
treat
infect
vivo
rhinoviru
vaccin
avail
use
human
lack
anim
model
also
limit
abil
conduct
preclin
studi
antivir
compound
limit
anim
model
option
human
rhinoviru
infect
least
part
consequ
high
host
speci
specif
virus
chimpanze
success
infect
gibbon
overt
ill
observ
infect
anim
intracrani
inject
viru
monkey
hamster
babi
mice
result
either
infect
http
diseas
variou
balbc
mous
model
recent
develop
util
studi
aspect
minorand
majorgroup
hrvinduc
diseas
mous
model
hrv
infect
test
show
limit
replic
viru
show
strong
serolog
data
suggest
cross
protect
howev
publish
data
includ
proof
vaccin
efficaci
thu
success
immunizationchallengeprotect
studi
anim
model
report
avail
new
experiment
small
anim
model
option
therefor
still
major
press
need
vaccinolog
field
year
cotton
rat
sigmodon
hispidu
shown
support
replic
broad
spectrum
human
virus
includ
respiratori
syncyti
viru
rsv
nonadapt
strain
human
influenza
measl
among
other
provid
model
capabl
correspond
infect
present
studi
evalu
cotton
rat
model
human
rhinoviru
infect
could
potenti
facilit
develop
test
vaccin
prophylact
therapi
aim
import
human
virus
stock
atcc
cat
strain
atcc
cat
produc
hela
ohio
cell
gener
gift
dr
dean
erdman
cdc
atlanta
ga
usa
cell
grown
minim
essenti
medium
contain
earl
salt
emem
fetal
bovin
serum
fb
gml
na
co
lglutamin
penicillinstreptomycin
maintain
medium
fb
replicationdefici
viru
gener
expos
stock
ultraviolet
light
min
ice
mjcm
infecti
viru
titer
determin
plaqu
assay
agaros
overlay
monolay
cell
line
describ
control
ablat
infect
four
eight
week
old
cotton
rat
gender
obtain
inbr
coloni
maintain
sigmovir
biosystem
inc
sbi
sera
sentinel
cotton
rat
coloni
time
period
experi
test
seroneg
rhinoviru
neutral
assay
seroneg
elisa
adventiti
respiratori
virus
eg
pneumonia
viru
mice
rat
parvoviru
rat
coronaviru
sendai
viru
mycoplasma
sp
oropharyng
fecal
cultur
test
neg
salmonella
sp
klebsiella
sp
pseudomona
sp
citrobact
sp
pup
obtain
mother
coloni
anim
hous
larg
polycarbon
cage
fed
diet
standard
rodent
chow
water
ad
libitum
experi
perform
follow
feder
guidelin
protocol
approv
sbi
institut
anim
care
use
committe
iacuc
cotton
rat
infect
intranas
immun
intramuscularli
im
isofluran
anesthesia
applic
solut
pfu
per
rat
im
immun
pfu
live
uvinactiv
pfu
lpol
polio
vaccin
carri
condit
serum
obtain
retroorbit
blood
collect
isofluran
anesthesia
pup
day
old
infect
viru
pfu
adult
anim
euthan
carbon
dioxid
asphyxi
pup
euthan
decapit
tissu
sampl
left
lung
lobe
entir
nose
trachea
adult
anim
homogen
ml
infect
medium
emem
fetal
calf
serum
gml
sodium
bicarbon
mm
hepe
penicillin
streptomycin
wherea
left
lung
lobe
pup
homogen
ml
infecti
viru
titer
determin
standard
plaqu
assay
express
plaqu
form
unit
pfu
g
tissu
briefli
pure
tenfold
serial
dilut
tissu
homogen
supernat
viru
stock
plate
triplic
onto
confluent
monolay
hela
oh
cell
plate
h
adsorpt
rock
everi
min
monolay
overlay
ml
low
melt
agaros
emem
contain
fb
follow
incub
day
monolay
fix
buffer
formaldehyd
stain
crystal
violet
neutral
antibodi
titer
determin
plaquereduct
assay
serial
fourfold
dilut
serum
incub
h
pfu
viru
incub
pb
use
control
neutral
mix
plate
quadrupl
onto
confluent
hela
cell
monolay
plate
incub
h
overlay
low
melt
agaros
mem
cell
incub
co
h
fix
buffer
formaldehyd
stain
crystal
violet
read
rna
isol
lung
lingular
lobe
use
rneasi
kit
qiagen
scienc
bronchoalveolar
lavag
bal
collect
total
rna
isol
dedic
group
infect
anim
lavag
time
total
ml
pb
mrna
assay
cdna
prepar
use
quantitect
revers
transcript
kit
qiagen
scienc
cdna
reaction
dilut
match
lg
initi
rna
per
final
cdna
volum
three
microlit
dilut
cdna
use
qpcr
reaction
qpcr
protocol
develop
use
primer
target
utr
genbank
access
quantit
assess
viral
replic
cdna
neg
strand
viral
rna
indic
activ
rna
transcript
synthes
prime
realtim
pcr
quantif
strand
perform
use
forward
primer
revers
primer
gener
fragment
bp
plasmid
contain
utr
dilut
gener
copi
number
standard
curv
allow
quantif
copiesg
tissu
neg
replic
intermedi
assess
cotton
rat
mrna
express
carri
previous
describ
right
lobe
lung
dissect
caudal
trachea
attach
lung
lobe
inflat
normal
volum
neutral
buffer
formalin
immers
fix
process
paraffinembed
section
stain
hematoxylin
eosin
h
e
addit
section
stain
alcian
blueperiod
acidschiff
abpa
visual
mucu
mucusbear
cell
lung
section
evalu
sever
indic
inflamm
cell
chang
conduct
airway
parenchym
alveolar
compart
describ
fulli
result
chang
assess
subject
score
blindli
scale
sever
absent
minim
mild
moder
mark
valid
score
done
two
pathologist
experienc
respiratori
viral
pathogenesi
grade
find
includ
peribronchiolar
inflammatori
cell
infiltr
bronchiol
bronchiolar
epitheli
degener
mucou
cell
hyperplasia
hypertrophi
airway
lumin
mucou
exud
perivascular
inflammatori
cell
infiltr
alveolar
septal
infiltr
alveolar
lumin
inflammatori
cell
exud
trachea
nasal
turbin
select
infect
anim
also
evalu
viral
titer
express
mx
gene
product
replic
intermedi
calcul
geometr
mean
standard
error
anim
group
given
time
post
infect
student
ttest
appli
determin
statist
signific
differ
two
group
use
unpair
twotail
test
set
p
pulmonari
patholog
score
express
arithmet
mean
standard
error
anim
group
signific
score
differ
uninfect
infect
group
differ
day
postinfect
histolog
paramet
analyz
one
way
kruskalw
anova
set
valu
p
adult
cotton
rat
infect
pfu
group
anim
euthan
min
h
day
postinfect
pi
fig
noninfect
anim
anim
inocul
uvinactiv
use
control
infecti
recov
nose
trachea
day
pi
lung
day
pi
viru
detect
tissu
anim
euthan
day
pi
tissu
uninfect
control
shown
highest
viru
titer
detect
lung
pfug
tissu
follow
nose
trachea
pfug
tissu
brief
plateau
viral
load
detect
nose
trachea
h
pi
follow
decreas
clearanc
viru
infect
lower
dose
pfuanim
result
lung
viral
titer
pfug
h
pi
n
detect
infecti
viru
h
pi
data
shown
compar
viral
load
lung
rat
infect
major
group
rat
infect
minor
group
found
cours
infect
virus
differ
fig
higher
infecti
viru
titer
recov
lung
anim
infect
anim
infect
similar
dose
suggest
cotton
rat
significantli
permiss
infect
base
result
use
subsequ
experi
lung
load
viru
also
examin
determin
product
replic
intermedi
neg
strand
viral
rna
vrna
pcr
fig
vrna
strand
detect
lung
infect
anim
h
pi
fig
see
also
inset
anim
inocul
uvinactiv
pfu
show
undetect
neg
strand
rna
appar
rapid
kinet
viral
replic
observ
vivo
consist
data
onestep
growth
curv
carri
hela
ohio
cell
show
complet
replic
cycl
occur
h
fig
measur
express
cotton
rat
gene
lung
respons
infect
evid
presenc
type
ifn
two
ifninduc
gene
mediat
antivir
activ
activ
express
detect
bal
cell
cotton
rat
h
pi
fig
either
two
subsequ
time
point
h
h
data
shown
indic
induct
ifn
transient
analysi
patholog
associ
infect
perform
nose
trachea
lung
signific
lesion
observ
nasal
turbin
section
epitheli
degener
present
trachea
larg
pulmonari
airway
rat
infect
associ
direct
pro
gressiv
damag
ciliat
columnar
epithelium
trachea
peak
day
pi
often
expos
basal
membran
fig
lung
patholog
demonstr
mild
signific
alveol
neutrophil
histiocyt
peribronchiolar
infiltr
neutrophil
macrophag
lymphocyt
fig
peak
damag
lung
parenchyma
perivascul
alveolar
septal
infiltr
alveol
record
day
pi
wherea
airway
damag
predominantli
seen
day
pi
mucou
cell
hypertrophyhyperplasia
evid
h
eand
abpasstain
lung
section
earli
day
pi
continu
elev
day
pi
fig
thu
infect
cotton
rat
reproduc
aspect
human
diseas
urt
detect
inflamm
lower
airway
lung
parenchyma
contrast
infect
result
signific
patholog
intramuscular
immun
adult
rat
live
dose
pfu
prime
day
boost
day
schedul
result
high
serum
level
neutral
antibodi
day
first
immun
surprisingli
case
amount
viru
instil
follow
ident
schedul
shown
tabl
anim
immun
intramuscularli
show
neutral
antibodi
titer
wherea
anim
underw
infect
reinfect
show
low
neutral
antibodi
titer
furthermor
anim
immun
im
pfu
challeng
day
later
pfu
infecti
viru
detect
nasal
turbin
trachea
reduct
log
infecti
viru
titer
detect
lung
fig
expect
intramuscular
immun
live
uvinactiv
pfu
current
polio
vaccin
ipol
fail
confer
measur
protect
upon
challeng
fig
possibl
observ
reduct
viral
titer
lung
anim
vaccin
im
caus
neutral
vitro
evalu
mix
equal
amount
lung
homogen
anim
lung
homogen
individu
vaccin
anim
euthan
h
pi
shown
fig
homogen
mix
yield
amount
viru
lung
suspens
predict
dilut
indic
proport
respect
without
evid
vitro
neutral
result
indic
protect
observ
due
bona
fide
immun
neutral
viru
ex
vivo
homogen
tissu
test
efficaci
prophylact
administr
immun
neutral
antibodi
titer
normal
cotton
rat
serum
protect
challeng
neutral
antibodi
titer
detect
treat
anim
prior
challeng
shown
tabl
anim
receiv
undilut
sera
neat
intraperitoneali
serum
dilut
h
prior
challeng
show
reduct
lung
viral
titer
log
respect
wherea
anim
receiv
dilut
immun
serum
cotton
rat
serum
pb
remain
unprotect
fig
data
indic
passiv
transfer
antibodi
effect
prophylact
therapi
hrv
infect
young
femal
cotton
rat
immun
twice
im
live
pfu
bred
unimmun
male
newborn
pup
deliv
immun
nonimmun
femal
gestat
time
hispidu
week
challeng
day
age
euthan
h
pi
pup
nonimmun
mother
show
lung
titer
consist
adult
cotton
rat
challeng
fig
pup
immun
mother
show
statist
signific
reduct
infecti
viru
titer
log
also
signific
reduct
viral
load
measur
copi
vrna
fig
neutral
antibodi
titer
pup
correl
level
lung
protect
fulli
protect
pup
anim
euthan
h
fig
show
neutral
titer
wherea
pup
euthan
h
post
infect
harbor
low
detect
viru
titer
show
neutral
antibodi
titer
suggest
correl
protect
serum
neutral
antibodi
titer
seen
adult
data
indic
matern
immun
confer
immun
transfer
newborn
pup
suffici
protect
offspr
viral
infect
possibl
replic
lung
morbid
mortal
attribut
rhinoviru
infect
consider
result
billion
dollar
health
care
cost
everi
year
despit
signific
problem
effect
prevent
hrv
infect
treatment
hrvassoci
diseas
current
avail
due
part
lack
reliabl
anim
model
suitabl
protect
studi
one
serotyp
classifi
within
major
group
use
wellcharacter
receptor
attach
entri
model
viru
studi
transmiss
rhinovirus
pathogenesi
common
cold
virusinduc
asthma
copd
evalu
antirhinoviru
drug
human
volunt
reproduc
induc
sever
symptom
human
subject
recent
use
vitro
studi
aim
defin
molecular
mechan
rhinovirusinduc
inflammatori
respons
airway
epitheli
cell
transgen
balbc
mice
express
humanmous
chimer
receptor
show
human
diseaserelev
outcom
includ
pulmonari
inflamm
mucin
product
infect
despit
low
level
viral
replic
detect
rtpcr
data
show
contrast
mous
requir
genet
manipul
cotton
rat
appear
host
infect
possibl
replic
urt
lrt
although
data
examin
viral
load
respiratori
tract
time
certainli
compat
nonpermiss
model
infect
clearanc
inoculum
time
differ
observ
cours
infect
togeth
detect
vrna
infect
tissu
suggest
may
actual
replic
cotton
rat
refin
real
time
qrtpcr
protocol
increas
specif
detect
strand
viral
rna
provid
abil
address
import
issu
better
describ
model
contrast
describ
respiratori
viral
infect
influenza
hrv
infect
cotton
rat
result
mild
epitheli
damag
vacuolar
degener
apic
bleb
bronchiol
slough
trachea
consist
previou
observ
human
unlik
laboratori
mous
either
lack
defect
mx
gene
cotton
rat
set
fulli
function
mx
gene
describ
human
mx
counterpart
cotton
rat
mx
gene
express
respons
infect
influenza
rsv
shown
present
studi
transient
mx
gene
express
detect
infect
coton
rat
bal
cell
h
post
infect
result
parallel
detect
mxa
express
nasal
epitheli
scrape
obtain
h
experiment
infect
human
result
describ
experiment
work
show
infect
cotton
rat
reproduc
aspect
hrvassoci
human
diseas
respiratori
tract
caus
detect
inflamm
lower
airway
lung
parenchyma
mucu
product
induc
transient
express
interferonstimul
gene
merit
investig
model
infect
pulmonari
infecti
viral
load
measur
within
h
follow
instil
thu
provid
power
readout
assess
protect
immun
passiv
transfer
neutral
antibodi
found
im
inocul
live
viru
uvinactiv
result
signific
decreas
viral
load
nasal
turbin
trachea
lung
challeng
anim
suggest
replic
site
inject
play
role
result
measur
protect
challeng
achiev
one
immun
fig
immunogen
inoculum
like
depend
upon
viral
replic
area
immun
sinc
uvinactiv
viru
complet
abolish
protect
protect
achiev
live
viru
specif
sinc
protect
confer
immun
live
result
could
due
appar
lack
replic
cotton
rat
respiratori
tract
data
shown
like
result
lack
share
neutral
epitop
spectrum
crossreact
cotton
rat
neutral
antibodi
investig
view
recent
report
regard
induct
vitro
crossneutr
antibodi
immun
recombin
weak
induct
bind
antibodi
neutral
antibodi
mous
immun
previou
studi
conduct
cotton
rat
demonstr
passiv
transfer
matern
immun
rsv
offspr
studi
show
immun
elicit
mother
im
immun
also
confer
complet
protect
day
old
pup
challeng
hrv
importantli
data
experi
strongli
suggest
newborn
cotton
rat
also
support
viral
replic
lrt
set
stage
futur
test
potenti
antibodybas
therapi
infant
cotton
rat
wellrecogn
pivot
role
develop
immunoglobulin
prophylact
treatment
rsvassoci
diseas
respigam
synagi
data
present
studi
demonstr
passiv
transfer
cotton
rat
hyperimmun
serum
also
effect
neutral
antibodi
titer
suffici
log
reduct
viral
load
lung
without
doubt
cotton
rat
model
use
determin
valu
differ
array
antirhinoviru
antibodi
vivo
challeng
experiment
design
although
high
divers
serotyp
character
group
virus
remain
major
challeng
develop
pancrossreact
antibodybas
intervent
work
conduct
use
cotton
rat
model
hrv
infect
gener
strong
evid
parenter
rout
immun
effect
therefor
disserv
addit
investig
given
import
question
rais
vaccinolog
field
regard
design
strategi
requir
effect
multival
hrv
vaccin
therapeut
antibodi
importantli
data
highlight
larg
potenti
cotton
rat
provid
experiment
platform
complementari
offer
avail
mous
model
evalu
immunogen
individu
hrv
capsid
protein
alreadi
identifi
antihrv
antibodi
document
neutral
activ
vitro
antibodi
target
select
domain
viru
receptor
well
altern
antibodybas
strategi
consider
support
new
develop
area
work
show
cotton
rat
host
infect
infecti
viru
neg
strand
vrna
load
detect
lung
infect
anim
within
h
follow
intranas
infect
infect
result
measur
patholog
mucu
product
express
inflammatori
mediat
intranas
infect
result
product
low
level
neutral
antibodi
confer
reduc
protect
rechalleng
intramuscular
immun
live
result
strong
typespecif
protect
correl
high
level
system
neutral
antibodi
addit
demonstr
passiv
transfer
antibodi
gener
vaccin
cotton
rat
protect
anim
infecti
viru
titer
lung
determin
plaqu
assay
indic
time
pi
b
viral
rna
detect
lung
newborn
cotton
rat
n
animalsgroup
group
consist
pup
differ
mother
p
student
ttest
comparison
group
pup
whose
mother
immun
vs
group
pup
age
unimmun
mother
pulmonari
infect
thu
result
demonstr
cotton
rat
suitabl
anim
model
challeng
studi
explor
develop
antirhinoviru
vaccin
antivir
therapi
